Phase 2Completed
A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
A Single Center, Randomized, Open-Label, Crossover Study, Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro Either in Combination With a Basal Insulin Infusion or With Insulin Glargine Relative to a Standardized Meal in Patients With Type 1 Diabetes
- Sponsor
- Biodel (Industry)
- Enrolment
- 24 enrolled
- Conditions
- Diabetes Mellitus
- Interventions
- Regular Human Insulin; Lispro; VIAject; VIAject 50%; VIAject/Insulin Glargine; Insulin Glargine/VIAject
- Ages
- adults, older adults
- Registry
- NCT01000922
Full record on ClinicalTrials.gov
From the registry
Evaluation of post-prandial blood glucose excursions after a standardized meal and pre meal injections of individual doses of the study insulins.
Primary outcomes
- To compare the maximal post prandial blood glucose concentration and the time to maximal post prandial glucose concentration between the different treatments
History
Last registry update
Registered
Primary completion
Started